Home
Newsroom
Cannabis
Commentary
Commodities
Cryptocurrencies
Entertainment & Retail
Financial
Food and Beverage
Med, Biotech & Pharma
Technology
Video
In Play
ASX Stocks
ASX Commentary
Cryptocurrency
Crypto in the News
Cryptocurrency list
Crypto Exchanges
Past ICO’s
Ongoing ICO’s
Upcoming ICO’s
Investor Tools
Caveat Emptor Status Changes
Market Movers
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, January 17, 2021
Contact Us / Subscribe
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
EmergingGrowth.com
Home
Newsroom
All
Cannabis
Commentary
Commodities
Cryptocurrencies
Entertainment & Retail
Financial
Food and Beverage
Med, Biotech & Pharma
Technology
Video
Med, Biotech & Pharma
Stocks involved in Covid-19 Testing could be the all out Winners
Food and Beverage
PUBLIC SNACK COMPANIES FIGHT FOR THE FUTURE OF THE CATEGORY
Technology
Penny Stocks Could Surge Over 300%
Technology
Hydrogen Stocks, The New EV
In Play
In Play
CytoDyn Update Reveals Q1 Sales Pipeline, Philippine EUA, NASDAQ Uplisting, &…
ASX Stocks
First Graphene (ASX: FGR) Extracts True Practicality from Rising Innovations
In Play
BuyersStrike Short Attack Ahead of NASDAQ Uplisting
In Play
Mesoblast Crashed on Poor DSMB Report Leaving CytoDyn as Sole Survivor…
In Play
Cracking the FDA Code to COVID-19 Approvals
ASX Stocks
ASX Commentary
Cryptocurrency
Crypto in the News
Cryptocurrency list
Crypto Exchanges
Past ICO’s
Ongoing ICO’s
Upcoming ICO’s
Investor Tools
Caveat Emptor Status Changes
Market Movers
- Or -
Tag: MRNA
In Play
Mesoblast Crashed on Poor DSMB Report Leaving CytoDyn as Sole Survivor...
Chris Long
-
December 18, 2020
Only Mesoblast (NASDAQ:MESO) and CytoDyn Inc. (OTCMKS: CYDY) had mortality as a primary endpoint in severe to critical COVID-19.